These results indicate that IL-13Rα2, a decoy receptor for IL-13, negatively regulates STAT6 activation and positively regulates IL-4R/IL-13R-mediated STAT3 activation in GBM cells. The gene discussed is IL4R; the disease is glioblastoma.